Other Events ·
NYSE American has accepted Picard Medical's compliance plan to address delisting risks related to stockholders' equity…
PMIPicard Medical, Inc.
NYSE American has accepted Picard Medical's compliance plan to address delisting risks related to stockholders' equity and recent financial losses. The company previously reported a stockholders' deficit of $1.4 million as of March 31, 2026, and losses in three of its four most recent fiscal years. This acceptance allows the company to maintain its listing on the NYSE American under the ticker PMI through a compliance period ending November 8, 2027, subject to quarterly reviews and the achievement of specific milestones. Picard Medical is a medical device company that develops and commercializes total artificial heart technology.